• Linoleic Acid–PPARα–TF Axis Drives Tumor Progression in pLEL

  2026-06-26

  This study uncovers how linoleic acid promotes tissue factor (TF) expression through PPAR-α, contributing to tumor progression in primary pulmonary lymphoepithelioma-like carcinoma (pLELC). Multiomics approaches and functional validation reveal TF as a promising therapeutic target, highlighting the regulatory bridge between dietary fatty acids, nuclear receptor signaling, and tumor microenvironment modulation.

• Rapakinin-Induced Vasorelaxation: NO-Independent Mechanisms

  2026-06-26

  The reference study reveals that rapakinin, a peptide from rapeseed protein, induces vasodilation in hypertensive rat arteries via the prostaglandin IP and CCK1 receptor pathways, independently of nitric oxide synthase inhibition. This finding challenges the conventional understanding of vasorelaxation mechanisms and provides a refined framework for vascular tone regulation studies.

• Nullscript (C3606): Reliable HDAC Inhibitor for Epigenetic A

  2026-06-25

  This article explores how Nullscript (SKU C3606) addresses common laboratory challenges in HDAC inhibition assays, focusing on data reproducibility, mechanistic selectivity, and translational research reliability. Scenario-driven Q&A blocks offer protocol guidance and candid product selection advice, ensuring researchers can confidently optimize experiments with Nullscript.

• VX-765: Precision Caspase-1 Inhibition for Pyroptosis Resear

  2026-06-25

  Explore how VX-765, a selective caspase-1 inhibitor, unlocks advanced insights into inflammasome signaling and targeted control of pyroptosis. Discover unique mechanistic analyses and practical workflow guidance not found in existing resources.

• hiPSC-Derived Intestinal Organoids for Pharmacokinetic Model

  2026-06-24

  Saito et al. introduce a streamlined protocol for generating human intestinal organoids from pluripotent stem cells, enabling robust in vitro pharmacokinetic studies. These organoids exhibit mature intestinal epithelial functions, offering a more reliable human model than traditional animal or cancer cell line systems.

• Dual-Sensitive Nanocarriers and ROS-Responsive Chemotherapy

  2026-06-23

  The reference study introduces a pH/ROS dual-sensitive nanocarrier (DATCPT) designed to overcome multiple physiological barriers in orthotopic pancreatic cancer, significantly enhancing chemotherapeutic efficacy. Through a cascade response to the tumor microenvironment, the system improves drug delivery, matrix remodeling, and inhibits metastasis, underscoring the importance of precise intracellular ROS measurement in evaluating advanced therapeutic strategies.

• Macrophage EV miR-660 Activates NF-κB to Drive Breast Cancer

  2026-06-23

  The reference study uncovers how tumor-associated macrophage (TAM)-derived extracellular vesicles (EVs) transfer microRNA-660 to breast cancer cells, silencing KLHL21 and activating NF-κB signaling to promote metastasis. These insights clarify a key immunological axis in tumor progression and highlight potential molecular targets for therapeutic intervention.

• PPM-18: Targeted iNOS Inhibition for Sepsis and Inflammation

  2026-06-22

  PPM-18 offers precise, reproducible inhibition of iNOS via NF-κB pathway blockade, giving researchers a robust tool for dissecting inflammation and sepsis mechanisms in both in vitro and in vivo settings. Its high solubility, stability, and specificity—supplied by APExBIO—streamline challenging workflows and mitigate common pitfalls in immune modulation studies.

• Pam3CSK4 and TLR1/2 Agonism: Precision Tools for Neuro-Immun

  2026-06-22

  Explore how Pam3CSK4, a potent TLR1/2 agonist, advances neuro-immune and inflammation research. This article uniquely bridges molecular immunology with translational insights from recent neural circuit discoveries.

• Macrophage EV miR-660 Activates NF-κB to Drive Breast Cancer

  2026-06-21

  This study demonstrates that microRNA-660, transferred via extracellular vesicles from tumor-associated macrophages, silences KLHL21 to activate NF-κB signaling in breast cancer cells. These findings clarify a tumor-promoting communication axis in the tumor microenvironment and suggest new intervention targets for metastatic breast cancer.

• nor-NOHA Acetate: Optimizing Arginase Inhibition Workflows

  2026-06-20

  nor-NOHA acetate stands out for its potent, reversible inhibition of arginase, enabling precise manipulation of arginine metabolism in cancer and endothelial research. This guide delivers proven protocols, troubleshooting strategies, and insights that connect metabolic reprogramming to immune escape and therapy resistance.

• Trichostatin A (TSA): HDAC Inhibition for Cancer Epigenetics

  2026-06-19

  Trichostatin A (TSA) is a potent histone deacetylase inhibitor used for epigenetic regulation in cancer research. It induces cell cycle arrest and differentiation in mammalian cells, with notable antiproliferative effects against breast cancer lines. APExBIO’s TSA (A8183) enables reproducible epigenetic modulation studies at nanomolar concentrations.

• Cholecystokinin Octapeptide Ammonium: Pathways, Potentials &

  2026-06-19

  Explore the multifaceted mechanisms of Cholecystokinin octapeptide ammonium (CCK-8 ammonium) as a brain–gut peptide, its precise receptor-driven actions, and advanced research applications. This article uniquely decodes signal transduction, assay context, and translational workflow considerations for CCK-8 ammonium studies.

• Tigecycline: Precision Targeting of MDR Bacteria in Modern R

  2026-06-18

  Explore how Tigecycline, a pioneering glycylcycline antibiotic, offers new precision in combating multidrug-resistant bacteria. This article delivers advanced insights into its mechanism, assay design, and practical implications for translational research.

• Human Gastrin I Peptide: Advanced Tools for GI Pathway Resea

  2026-06-18

  Human Gastrin I peptide enables precise dissection of gastric acid secretion pathways, especially in advanced organoid and stem cell-based models. Explore best-practice workflows, critical troubleshooting, and protocol enhancements that position this reagent from APExBIO as a top choice for translational gastrointestinal physiology studies.

16889 records 1/1126 page Next 12345 下5页 Last page